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Abstract: Novel poly (ethylene oxide) (PEO) hydrogel films were synthesized via UV cross-linking
with pentaerythritol tetra-acrylate (PETRA) as cross-linking agent. The purpose of this work was to
develop a novel hydrogel film suitable for passive transdermal drug delivery via skin application.
Hydrogels were loaded with model drugs (lidocaine hydrochloride (LID), diclofenac sodium (DIC)
and ibuprofen (IBU)) via post-loading and in situ loading methods. The effect of loading method
and drug physicochemical properties on the material and drug release properties of medicated
film samples were characterized using scanning electron microscopy (SEM), swelling studies,
differential scanning calorimetry (DSC), fourier transform infrared spectroscopy (FT-IR), tensile
testing, rheometry, and drug release studies. In situ loaded films showed better drug entrapment
within the hydrogel network and also better polymer crystallinity. High drug release was observed
from all studied formulations. In situ loaded LID had a plasticizing effect on PEO hydrogel, and films
showed excellent mechanical properties and prolonged drug release. The drug release mechanism
for the majority of medicated PEO hydrogel formulations was determined as both drug diffusion and
polymer chain relaxation, which is highly desirable for controlled release formulations.
Keywords: poly (ethylene oxide); pentaerythritol tetra-acrylate; hydrogel; lidocaine hydrochloride;
diclofenac sodium; ibuprofen
1. Introduction
The feasibility of hydrogel film patches as vehicles for transdermal drug delivery was first
acknowledged in the late 80’s [1]. Since then, a variety of natural and synthetic polymers such as
gelatin, pectin, chitosan, and poly (vinyl alcohol) have been studied for potential application in
this area [2,3]. Synthetic polymer poly (ethylene oxide) (PEO) is FDA-approved due to negligible
immunogenicity issues and absence of residues or vaporous elements when applied onto skin. Besides,
high molecular weight grades of PEO have high viscosity promoting the formation of strong, solid
gels for transdermal application.
The fabrication of PEO hydrogels via ultraviolet (UV) radiation is advantageous in terms of
health and safety aspects, cost and efficiency; also, UV cross-linked pure PEO hydrogel films have
shown significantly stronger mechanical profiles than those obtained from electron beam, with Young’s
moduli similar to those of human skin [4]. Due to lack of photosensitive chromophoric groups in
PEO, the addition of cross-linkable moieties, such as acrylate groups, is essential to initiate the UV
crosslinking process [5]. The principal concern of this cross-linking method is the presence of residual
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acrylate monomer. However, the inclusion of pentaerythritol tetraacrylate (PETRA) as cross-linking
agent was evaluated to be safe for dermatological application as long as it is within the maximum
acceptable limit of 10% w/w [6].
The ability of hydrogel film formulations to deliver a drug transdermally via passive diffusion
typically relies on its inherent network properties, drug-polymer interactions, amount of entrapped
drug, and drug solubility. To the best of our knowledge, a detailed description of these on PEO
films has not been reported before. Therefore, the aims of this work are: (1) to explore different drug
loading methods onto PEO hydrogel films and their effect on the properties of resultant formulations;
(2) to investigate the effect of hydrophilic and lipophilic model drugs: lidocaine hydrochloride (LID),
diclofenac sodium (DIC), and ibuprofen (IBU) on the microstructure of PEO hydrogel films; and (3) to
characterize the passive permeation profiles of selected drug loaded PEO hydrogel formulations via
diffusion studies. LID and DIC were chosen as hydrophilic/ionized model drugs and IBU was chosen
as a lipophilic model drug.
LID is one of the most commonly administered local anesthetics due to its efficacy, reliability
and low toxicity. However, this hydrophilic drug often exists in ionized form, causing it to be
rarely applied percutaneously due to its poor penetration through intact skin. The non-steroidal
anti-inflammatory drug (NSAID) DIC is one of the most frequently prescribed drugs, possessing
anti-inflammatory, analgesic and anti-pyretic properties. Since it is highly water insoluble, salt forms
are often preferred in commercial formulations to avoid solubility problems. Similarly, IBU is one of
the best tolerated NSAID, despite its low water solubility and poor gastrointestinal absorption. Due to
the aforementioned solubility reasons and systemic side effects, the transdermal administration of
NSAIDs has been studied using various formulation approaches [7]. At present, Voltarol® is the only
NSAID patch available in the UK. This medicated plaster marketed as gel patch, contains 1% w/w
diclofenac epolamine and is licensed for local symptomatic treatment of pain in epicondylitis and
ankle sprain [8]. The physicochemical properties of all model drugs are summarized in Table 1.
Table 1. Physicochemical properties of model drugs.
Model drug Molecular structure Solubility in water Log P pKa Melting point
LID
Water Soluble
(50 mg/mL) [9]
Less than or equal
to zero [10]
7.86 [11] 75–79 ◦C [9]
DIC
Water Soluble
(20 mg/mL) a
0.70 [12] 4.15 [13] 288–290 ◦C [14]
IBU
Slightly Soluble
(21 mg/L at 25 ◦C) [15]
3.97 [15] 4.91 [15] 75–77.5 ◦C [15]
a Experimental value.
2. Materials and Methods
2.1. Materials
Polyethylene oxide (PEO) (Mw ≈ 1,000,000 g/mol), pentaerythritol tetraacrylate (PETRA),
Lidocaine hydrochloride (LID), and Diclofenac Sodium (DIC) were purchased from Sigma-Aldrich,
(Dorset, UK). Ibuprofen (IBU) was from Knoll Pharmaceuticals (Nottingham, UK). All materials were
used as received. Distilled water (Triplered, Long Crendon, UK) was used for dissolving PEO and
model drugs, and swelling of PEO hydrogel films.
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2.2. Synthesis of PEO Hydrogel Films
8 g of PEO were premixed in distilled water (100 mL) under intensive stirring (IKA ®Werke
GmbH & Co. KG, Straufen, Germany) for 24 h until a homogeneous gel like mixture was formed.
PETRA was then added into the premixed gel, and the entire mixtures were further stirred for 8 h until
homogeneous. The cross-linker concentration was fixed at 5% w/w, as this concentration was found
to be optimum in producing gel films with good mechanical properties [4], as well as being safe for
dermatological application [6]. The viscous mixture was allowed to stand for 16 h to remove entrapped
air bubbles before it was cast onto a glass tile (dimension = 30 cm × 30 cm). The cast gel was dried in
a fume cupboard at room temperature (22 ◦C) for two days to form a xerogel film. The thickness of the
xerogel film was measured using a micrometer (Duratool, Taichung, Taiwan), and was found to be
200 µm. The circular film was then cut into smaller rectangular pieces (3 cm × 5 cm).
2.3. UV Irradiation of PEO Hydrogel Films
The irradiation process was carried out using a 150 W medium pressure mercury lamp (TQ 150
Heraeus Noblelight GmbH, Kleinostheim, Germany, UV emission = 248–579 nm, λmax = 366 nm),
installed inside a quartz jacket within a cylindrical quartz tube. Each piece of film was individually
fixed on the inner glass wall of the UV reactor, with approximately 4 cm directly below the head for
perpendicular irradiation to achieve optimal light intensity. The total irradiation time was 11 min
under a flow of nitrogen. The films were turned upside down after 5.5 min.
2.4. Drug Loading
Model drugs, LID, DIC, and IBU were loaded into the hydrogel films via two different methods [16].
2.4.1. Post-Loading
Six replicates of unmedicated dry hydrogel films were immersed in 25%, 50%, 75%, and 100%
saturated model drug solutions at 32 ◦C for 24 h. LID and DIC solutions were prepared using distilled
water as solvent, while the solvent for IBU solution was ethanol water (50:50). Preliminary studies
showed that 32 ◦C and 24 h were the optimum conditions to ensure maximum drug load. The fully
saturated drug solution concentrations at 32 ◦C were 9.13% w/v for LID, 1.98% w/v for DIC, and 8.01%
w/v (in 50% w/v ethanol solution) for ibuprofen. After 24 h, the loaded hydrogels were weighed and
placed in the vacuum oven for 24 h to dry completely. The dried xerogel films were then weighed and
the drug load was determined by using Equation (1). This equation was adapted from Peppas et al.,
as the weight of drug was taken into account [17].
Drug Loading (%) =
(
MD −M0
M0
)
× 100% (1)
whereM0 is the initial weight of xerogel andMD is the weight of drug-loaded xerogel.
2.4.2. In Situ Loading
The calculated amount of model drugs (lidocaine and diclofenac) were weighed and initially
dissolved in distilled water. PEO powder was then added to the solution under intensive stirring, as
previously described in Section 2.2. In order to compare both loading methods, the exact amount of
model drug was included in the mixture, based on the corresponding drug load obtained from
immersions in 25%, 50% 75% and 100% saturated drug solutions, as described in post-loading
method. Ibuprofen was not loaded via this method, as major phase separation was observed from the
synthesized drug loaded hydrogel films due to its hydrophobic nature.
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2.5. Scanning Electron Microscopy
The morphology of drug loaded hydrogel samples fabricated by both loading methods was
evaluated using a scanning electron microscope (Hitachi, Tokyo, Japan) operated in high vacuummode
at an accelerating voltage of 5 kV. The swollen hydrogel samples were transferred into liquid nitrogen
for 10 min, and freeze-dried in an ALPHA 2-4/LSC device (Martin Christ Gefriertrocknungsanlagen
GmbH, Osterode am Harz, Germany) under a vacuum of 0.1 Pa at −70 ◦C for 48 h to thoroughly
remove the water. The freeze-dried hydrogel samples were put into liquid nitrogen for a sufficient
length of time, fractured with a razor blade to expose the internal structures, and stuck onto the sample
holder. All samples were sputter-coated with gold for 2 × 105 s before observation.
2.6. Differential Scanning Calorimetry
Differential scanning calorimetry (DSC) of pure compounds and hydrogel samples was performed
using a DSC Q1000 (TA instrument, New Castle, DE, USA) calibrated with indium standard.
Film samples (2–4 mg) were accurately weighed using a microbalance (Mettler-Toledo, Greifensee,
Switzerland), placed in an aluminium hermetic sample pan and sealed with a lid. The samples
were subjected to standard heat/cool/heat cycles (heating and cooling rate were 10 and 5 ◦C/min
respectively), under a constant flow of nitrogen (50 mL/min). Samples were subjected to first heating
past expected melting points in order to examine the material in ‘as received’ condition, then cooled
and reheated from a temperature below Tg to above melting point in order to investigate crystalline
to amorphous transitions. The heating and cooling temperatures applied for each sample type is
summarized in Table 2. All DSC runs were performed in triplicate. The first heating cycle is represented
as cycle 1, cooling as cycle 2, and second heat as cycle 3. The second heating cycles of these runs were
used to determine the glass transition temperature (Tg).
Table 2. DSC temperature runs.
DSC heat/cool/heat temperature Sample type
−80 ◦C/100 ◦C/−80 ◦C
Pure PEO, unmedicated PEO xerogel, LID, IBU, LID xerogels
(post-loaded and in situ loaded), IBU xerogel (post-loaded)
−80 ◦C/350 ◦C/−80 ◦C
Unmedicated PEO xerogel, DIC, DIC xerogels (post-loaded
and in situ loaded)
The effect of loaded drugs on the crystallinity of the xerogel’s polymeric network was assessed
based on the percentage crystallinity (Xc) calculation, as shown in Equation (2) [18].
Xc (%) =
∆Hf(Tm)
∆Hf(Tmo)
× 100% (2)
where ∆Hf(Tm) is the enthalpy of fusion measured at melting point Tm from second heat, and
∆Hf(Tm
o) is the enthalpy of fusion of a 100% crystalline polymer measured at melting point
equilibrium melting point Tm
o (196.8 J/g for PEO) [19].
2.7. Fourier Transform Infrared Spectroscopy
Fourier Transform Infrared Spectroscopy (FT-IR) was performed to verify the presence of drug in
the hydrogel film and to investigate possible interactions with PEO. FT-IR absorption spectra of pure
compounds and xerogel film samples were obtained using a Shimadzu IRAffinity-1S Fourier Transform
Infrared Spectrometer (Shimadzu UK Ltd., Milton Keynes, UK) at room temperature. The spectral
range was 4000–550 cm−1 and the resolution was 2 cm−1.
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2.8. Swelling Measurements
Four replicas of pre-weighed in situ loaded xerogel discs (10mmdiameter) from each sample batch
were swollen to equilibrium in 500 mL distilled water for 72 h at 25 ◦C. For accurate measurements, the
swelling medium was replaced daily to ensure complete removal of loaded drugs. The equilibrated
hydrogel discs were removed from water, blotted with filter paper, and weighed. The equilibrium
swelling of each sample was calculated using Equation (3), which was adapted from Omidian et al.,
as the weight of drug was taken into account [20].
Equilibrium Swelling (%) =
Ms − (MD − D)
(MD − D)
× 100% (3)
where Ms is the weight of swollen gel at equilibrium and D is the weight of loaded drug.
At the end of the swelling experiment, the thickness of the swollen gel discs were measured and
recorded. The samples were dried in a vacuum oven until constant weight values were attained and
reweighed. The gel fraction was calculated using the following equation, which was adapted from
Yoshii et al., with weight of drug taken into account [21].
Gel Fraction (%) =
M′
(MD − D)
× 100% (4)
whereM′ refers to the weight of xerogel after extraction of water.
Determination of Average Molecular Weight between Cross-Links, Cross-Linking Density, and Mesh Size
The calculation of average molecular weight between two adjacent cross-links (Mc ), cross-linking
density (ρc), and mesh size (ξ) of all PEO hydrogel formulations was based on the equilibrium swelling
theory, assuming Gaussian distribution of cross-linked polymer chains. Since the non-ionic hydrogel
samples were cross-linked in a dry state, the following equation suggested by Flory and Rehner was
used to estimate Mc [22]:
1
Mc
=
2
Mn
−
(
υ
V1
)
[ln(1−V2,s) +V2,s +X1
(
V2,s)
2
]
[
(
V2,s)
1
3 −
V2,s
2
] (5)
where Mn is the number average molecular weight of the polymer, υ is the specific volume of
polymer (i.e., the reciprocal of polymer density, ν = 0.833 cm3/g for PEO), V1 is the molar volume of
water (18.1 cm3/mol), V2,s is the polymer volume fraction, and X1 is the polymer-solvent interaction
parameter (for water-PEO interaction, X1 = 0.45 at ~25
◦C [23].
Mn was calculated using the molar mass dispersity (Đ):
Đ =
Mw
Mn
(6)
Đ, formerly known as the polydispersity index (PDI), is defined as a measure of dispersion of
macromolecular species in a sample polymer [24]. Đ of PEO (Mw ≈ 1,000,000 g/mol) was not provided
by Sigma Aldrich, but was determined using size exclusion chromatography by Stokes [25], and was
found to be approximately 1.8.
The polymer volume fraction (V2,s), was determined as follow [26]:
V2,s =
[
1+
ρp
ρw
(
Ms
(MD −D)
− 1
)]−1
(7)
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where Ms
(MD−D)
is the weight swelling ratio of swollen hydrogel at equilibrium, ρp is the polymer
density (1.2 g/cm3 for PEO) [26], and ρw is the solvent density (1.00 g/cm3 for water).
Subsequently, the cross-linking density (ρc) was calculated using Mc [20,27]:
ρc =
(
ν . Mc
)−1
(8)
The theoretical mesh size (ξ) of hydrogel samples was estimated according to Equation (9) [27].
ξ = (V2,s )
−
1
3 (
2 CnMc
Mr
)
1
2
l (9)
where Cn is the polymer characteristic ratio (4.1 for PEO) [20], Mr is the molecular weight of the
repeating units of the composed polymer (44 g/mol for PEO), and l is the average bond length along
the polymer chain (1.54
.
A for PEO) [28].
2.9. Tensile Testing
Tensile strength and Young’s modulus of film samples were obtained with a Lloyd LS1 Material
Tester (AMETEK Test and Calibration Instruments, Largo, FL, USA) at room temperature (22 ◦C), using
a 5.6 N load cell, 21 mm/min preload stress speed, and extension rate of 10 mm/min. Three replicas of
unmedicated and drug loaded hydrogel films were cut into rectangular shapes, with a gauge length of
50 mm and width of 10 mm. The samples were clamped and subjected to tension until breakage.
2.10. Measurement of Rheological Properties
The rheological properties of unmedicated and drug loaded PEO hydrogel films were determined
with a Malvern Kinexus rotational rheometer (Malvern Instruments Ltd., Malvern, UK), equipped with
a 20 mm diameter stainless steel parallel plate. Oscillatory measurements were carried to measure the
moduli of the films as a function of shear strain (Amplitude Sweep test) and as a function of frequency
(Frequency Sweep test). The film sample was fixed between the upper parallel plate and stationary
surface, with the gap size set according to individual swollen film thickness (320–470 µm). All tests
were performed in triplicate at 32 ± 0.1 ◦C.
Amplitude Sweep. The linear viscoelastic region (LVR) of all samples was determined with
an amplitude sweep at incremental shear strains (1 to 106 Pa) and a fixed frequency of 1 Hz.
Frequency sweep test was performed subsequently after identifying the appropriate stress and strain
values, which were within the field of LVR.
Frequency Sweep. Frequency sweep measurements of film samples were carried out at decreasing
oscillating frequencies from 100 to 0.1 rad/s Hz. The mean elastic modulus (G’) and viscous modulus (G”)
were plotted vs. frequency.
2.11. In Vitro Drug Permeation Studies
2.11.1. pH Analysis
Three replicates of unmedicated and selected formulations containing the highest drug load
from both loading methods were initially swollen with distilled water, and their apparent pH
values were measured using a Jenway 3010 pH meter (Cole-Palmer Ltd., Staffordshire, UK).
The percentage ionization values of all model drugs present in the formulations were calculated
using Equation (10) [29].
Ionization (%) =
100
1+ anti log (pH− pKa)
(10)
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2.11.2. Release Medium
Drug permeation studies were performed in pH 7.2 phosphate buffer, which was prepared by
dissolving phosphate buffer saline tablets in a specified amount of distilled water.
2.11.3. Drug Permeation Studies
Drug permeation studies were performed on selected formulations containing the highest drug load
from both loading methods. Four replicates of drug loaded xerogels and one unmedicated xerogel of
known weight and dimension (1 cm × 1 cm) were initially swollen and individually sealed between
an ethylene-vinyl acetate (EVA) membrane (Co Tran 9702 by 3MHealthcare Ltd., Loughborough, UK)
and an impermeable backing layer to form a reservoir device. This was then transferred into a beaker
containing 10 mL of pH 7.2 phosphate buffer (20 mL for DIC and IBU loaded hydrogels), with the
EVA membrane facing towards the release medium. To avoid evaporation of medium, the beakers
were sealed with aluminum foil. The entire study was performed at 32 ◦C under gentle stirring using
a magnetic stirrer. At designated time points, the release medium was completely removed and
replaced with fresh phosphate buffer, which had been preheated to 32 ◦C. Samples were collected at
designated time intervals and their corresponding drug concentrations were measured in triplicate
using UV-visible spectroscopy. At the end of the study, the hydrogels were removed from the reservoir
system and placed in a vacuum oven at 40 ◦C for 24 h for complete moisture removal. The resultant
xerogels were then accurately weighed, and the obtained weights were used to cross check the total
percentage drug release using Equation (11), which was adapted from Equation (1).
Total percentage drug release (%) =
(
MD − MR
Weight o f Loaded Drug
)
× 100% (11)
whereMR is the weight of xerogel after the release study.
The drug release profiles for all tested formulations were evaluated using the following equations
corresponding to different kinetic models:
1. Zero-order kinetics [30]
F = K0 t (12)
where F is the fraction of drug release at time t and K0 is the zero order release constant.
2. First-order kinetics [31]
ln(1− F) = −K1t (13)
where K1 is the first order release constant.
3. Higuchi model [32]
F = −K2t
1/2 (14)
where K2 is the Higuchi constant.
4. Korsmeyer-Peppas Model [33]
Mt
M∞
= K3t
n (15)
where MtM∞ is the fraction of drug release at time t, K3 is the release rate constant, and n is the
release exponent. The different release mechanisms were characterized using the calculated
n value. When n < 0.5, the diffusion mechanism is quasi-Fickian, n = 0.5 is Fickian diffusion,
0.45 < n < 1 refers to non-Fickian diffusion, n = 1 is case-II transport, and n > 1 refers to super
case-II transport [34].
2.12. Statistical Analysis
Statistical analysis was performed using SPSS 17.0 (SPSS Inc., Chicago, IL, USA) to determine
statistical differences. The data obtained from swelling studies, DSC, tensile tests, rheological studies,
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and permeation studies were analysed by one-way analysis of variance (ANOVA). The subgroupmeans
were compared by post hoc Scheffe’s test. Statistical significance for all tests was set at a probability of
p < 0.05.
3. Results and Discussion
3.1. Effect of Drug Physicochemical Properties on the Percentage Loading of Post-Loaded Hydrogels
The percentage loading of model drugs into hydrogels obtained from post-loading method
was evaluated and summarized in Figure 1. Highly correlated (R2 > 0.99) linear loading trends
were obtained for all model drugs. The highest saturated loading percentage was achieved by
IBU (59.08 ± 3.97%), indicating good capability of PEO hydrogels in accommodating hydrophobic
compounds. This was followed by DIC (20.68 ± 0.47%) and LID (9.75 ± 0.75%). The calculated
standard deviation of loading percentages obtained from all LID and DIC loaded hydrogels were at
least 5 times lower than those of IBU loaded hydrogels, indicating a more homogeneous drug load.
This is expected, due to the hydrophilic nature of LID and DIC possessing better compatibility with
the hydrophilic polymer matrix.
Figure 1. Effect of drug physicochemical properties on the percentage loading of post-loaded hydrogels.
Error bars represented the standard deviation (n = 6) of samples.
3.2. Effect of Loading Method and Drug Physicochemical Properties on the Morphology Characteristics
The scanning electron microscopy (SEM) has been widely used to study the hydrogel’s surface
topography and its characteristic network structure [35]. Figures 2–6 show the scanning electron
micrographs of medicated PEO hydrogel network loaded via both methods in comparison to the
unmedicated hydrogel network. From Figures 2–4 (images B–E), it can be visually observed that
all post-loaded formulations were homogeneously loaded. The model drugs were loaded by first
occupying the existing interconnected microporous spaces of the hydrogel network. As the drug
saturation increased, more drugs were found deposited onto the film surface. The small amorphous LID
particles (Figure 2, images B2–E2) were found sticking together to form bigger particles. This is especially
obvious at the highest load (Figure 2, images E1–E3). Both DIC (Figure 3, images B2 and C2) and IBU
(Figure 4, images B2–D2) initially appeared as amorphous forms when loaded in lower saturation (up to
50% saturation for DIC and 75% saturation for IBU). At saturated loading, rod-shaped crystals and smooth
spherical aggregates were observed for DIC (Figure 3, images D3 and E3) and IBU (Figure 4, images E1–E3)
respectively. The crystalline drug was non-homogeneously distributed, and is identified as diclofenac
acid from DSC and FT-IR. Overall, the sponge like structure of unmedicated hydrogels was retained
when films were post-loaded (Figures 2–4, images B4–E4). In contrast, the morphologies of films were
distinctively different when drugs were loaded in situ (Figures 5 and 6, images B–E). The model drugs
were also found embedded on the polymeric network instead of microporous spaces. Presence of
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LID (Figure 5, images B3–E3) generated more micropores, and a gradual increment on the mesh
size was observed as the drug load increased. Moreover, the amorphous structure of LID was
also found to appear differently from the post-loaded ones. For the case of in situ loaded DIC
hydrogels (Figure 6, images B–E), films containing 3.17% w/w DIC (Figure 6, images B1–B3) possessed
significantly larger mesh size when compared to the unmedicated ones (Figure 6, images A1–A3).
Hydrogels loaded with 8.37% w/w (Figure 6, images C1–C3), 13.12% w/w (Figure 6, images D1–D3),
and 20.25% w/w (Figure 6, images E1–E3) DIC were found to be non-homogeneously cross-linked,
as irregular distributions of micropores were showcased. Furthermore, their corresponding cross
section micrographs featured absence of sponge-like structure (Figure 6, images C4–E6), indicating
scarcity of cross-links within the gel network. No rod-shape crystals were observed at higher drug
load (Figure 6, images D1–E3) indicating that the drug was present in an amorphous state.
Figure 2. SEM images of post-loaded LID hydrogel network in comparison to unmedicated hydrogel
cross-linked with 5% w/w PETRA. (A) Unmedicated PEO, (B) PEO-LID 1.18% w/w (25% saturation),
(C) PEO-LID 3.64% w/w (50% saturation), (D) PEO-LID 6.31% w/w (75% saturation), (E) PEO-LID
9.75% w/w (100% saturation). Scale bars are 100, 50 and 5 µm for micrographs featuring the outer
surface of hydrogel network (1–3), 100, 50, and 10 µm for micrographs featuring the cross section of
hydrogel network (4–6).
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Figure 3. SEM images of post-loaded DIC hydrogel network in comparison to unmedicated hydrogel
cross-linked with 5% w/w PETRA. (A) Unmedicated PEO, (B) PEO-DIC 3.28% w/w (25% saturation),
(C) PEO–DIC 8.39% w/w (50% saturation), (D) PEO-DIC 13.62% w/w (75% saturation), (E) PEO-DIC
20.68% w/w (100% saturation). Scale bars are 100, 50 and 5 µm for micrographs featuring the outer
surface of hydrogel network (1–3), 100, 50, and 10 µm for micrographs featuring the cross section of
hydrogel network (4–6).
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Figure 4. SEM images of post-loaded IBU hydrogel network in comparison to unmedicated hydrogel
cross-linked with 5% w/w PETRA. (A) Unmedicated PEO, (B) PEO-IBU 15.44% w/w (25% saturation),
(C) PEO-IBU 31.01% w/w (50% saturation), (D) PEO-IBU 45.48% w/w (75% saturation), (E) PEO-IBU
59.09% w/w (100% saturation). Scale bars are 200, 50 and 5 µm for micrographs featuring the outer
surface of hydrogel network (1–3), 100, 50, and 10 µm for micrographs featuring the cross section of
hydrogel network (4–6).
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Figure 5. SEM images of in situ loaded LID hydrogel network in comparison to unmedicated hydrogel
cross-linked with 5% w/w PETRA. (A) Unmedicated PEO, (B) PEO-LID 1.12% w/w, (C) PEO-LID
3.57% w/w, (D) PEO-LID 6.30% w/w, (E) PEO-LID 9.93% w/w. Scale bars are 200, 50, and 5 µm for
micrographs featuring the outer surface of hydrogel network (1–3), 100, 50, and 10 µm for micrographs
featuring the cross section of hydrogel network (4–6).
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Figure 6. SEM images of in situ loaded DIC hydrogel network in comparison with unmedicated
hydrogel cross-linked with 5% w/w PETRA. (A) Unmedicated PEO, (B) PEO-DIC 3.17% w/w,
(C) PEO-DIC 8.37% w/w, (D) PEO-DIC 13.12% w/w, (E) PEO-DIC 20.26% w/w. Scale bars are 200 µm,
50 µm and 5 µm for micrographs featuring the outer surface of hydrogel network (1–3), 100 µm, 50 µm,
and 10 µm for micrographs featuring the cross section of hydrogel network (4–6).
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3.3. Effect of Drug Physicochemical Properties on the Swelling Properties of In Situ Loaded Hydrogels
The polymeric networks of all in situ loaded formulations were compared to the unmedicated
ones via swelling studies. The resultant findings were tabulated in Table 3. It should be noted that
swelling studies were not performed on the post-loaded formulations, as similar morphologies to
the initial unmedicated film was observed from SEM. From Table 3, it can be seen that in situ drug
loading of hydrogels causes marked changes to the gel network, as the obtained equilibrium swelling
percentages, Mc, ρc, and ξ of all medicated films (except those containing 1.12% w/w LID) were
significantly different from the unmedicated film. This also means that 1.12% w/w LID was insufficient
to cause significant changes on the network properties of blank PEO gels. Nonetheless, all in situ loaded
formulations (except those loaded with 13.12% and 20.26% w/w DIC) fall under the same gel class
as the unmedicated gel, which were non-porous, with mesh size (ξ) values between 1 and 10 nm [4].
In situ loaded gels containing 13.12% and 20.26% w/w DIC exhibited similar network properties as
PEO gels cross-linked with 1% w/w PETRA [4]. The increase of LID and DIC concentration reduced
the cross-linking of the gel network, indicating possible interaction between drug and excipients.
The large standard deviations obtained from the swelling parameters of in situ loaded DIC hydrogels
correlated well with SEM observations of being non-homogeneously cross-linked.
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Table 3. Effect of drug physicochemical properties on the dependent variables involved in the swelling studies of in situ loaded PEO hydrogel films. Values in brackets
indicate the standard deviation from the reported mean. (n = 4, * Significantly different from unmedicated hydrogel; p < 0.05).
PEO (Mw = 1000,000 g/mol) hydrogel cross-linked with 5% w/w PETRA
Independent parameter Unmedicated
LID (% w/w) DIC (% w/w)
1.12 3.57 6.30 9.93 3.17 8.37 13.12 20.26
Dependent parameters
Thickness of dry film (µm) 200 200 200 200 200 200 200 200 200
Thickness of swollen film (µm) 320 320 320 340 345 355 380 420 485
Equilibrium Swelling (%)
199.84
(±9.24)
203.37
(±2.34)
255.11 *
(±9.22)
288.55 *
(±6.46)
306.14 *
(±8.79)
399.48 *
(±9.94)
514.71 *
(±19.43)
583.15 *
(±41.51)
736.07 *
(±84.93)
Gel Fraction (%)
85.84
(±1.65)
82.03 *
(±0.31)
81.51 *
(±0.98)
80.52 *
(±1.01)
79.54 *
(±0.42)
76.34 *
(±1.72)
71.24 *
(±4.56)
62.16 *
(±5.81)
57.26 *
(±7.34)
Average Molecular Weight Between
Cross-links, Mc (g/mol)
734.48
(±62.36)
756.54
(±57.15)
1187.03 *
(±84.17)
1508.77 *
(±68.17)
1710.96 *
(±136.21)
2921.48 *
(±179.43)
4856.94 *
(±363.97)
6243.55*
(±886.04)
9927.18 *
(±2424.43)
Cross-link Density, ρc × 10
−4
(mol/cm3)
16.45
(±1.56)
15.87 (±0.36) 10.16 * (±0.77) 7.92 * (±0.36)
7.05 *
(±0.50)
4.12 *
(±0.26)
2.48 *
(±0.19)
1.96 *
(±0.27)
1.26 *
(±0.22)
Mesh Size, ξ (nm)
2.73
(±0.08)
2.76 (±0.04) 3.65 * (±0.06) 4.26 * (±0.12)
4.60 *
(±0.13)
6.45 *
(±0.25)
8.93 *
(±0.43)
10.49 * (±0.96)
14.14 *
(±2.12)
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3.4. DSC Analysis
DSC was performed on pure drugs and PEO to establish their thermal parameters, and on
unmedicated and drug loaded xerogel films to determine the presence of crystals in the films. For pure
PEO, the average melting temperature (Tm) obtained from first and second heat was 69.1 ± 0.2 and
65.2 ± 0.2 ◦C respectively, with melting enthalpy of fusion (∆Hf) respectively being 191.7 ± 3.3 and
123.7 ± 4.7 J/g. The lower polymer melting endotherm observed in second heat indicated a small
decrease in polymer crystallinity. In addition, the polymer Tg, which was expected to occur between
−50 to −57 ◦C [36] was not found present in corresponding thermograms. Similar observation to
this had been recorded in literature [37–39]. Reason for it might be the high crystallinity of samples,
as high molecular weight PEO are highly crystalline thermoplastics [40]. After cross-linking, the
Tm from first and second heating of resultant unmedicated films respectively occurred at 65.3 ± 0.2
and 63.1 ± 0.9 ◦C when heated up to 80 ◦C. The films were also heated up to 350 ◦C, and their
Tm from first and second heating respectively occurred at 69.7 ± 0.8 and 57.0 ± 0.5
◦C. The Tm
difference is found to be statistically significant, indicating thermal behaviours of PEO hydrogels were
significantly affected by different thermal conditions. Hence, both values of Tm were assigned as
standard references. Pure LID exhibited a sharp endothermic peak with Tm at 78.4 ± 0.2
◦C when
first heated. The drug remained amorphous after the first melt, as no melting point was detected
at second heat, and a subtle Tg occurred at 32.9 ± 0.2
◦C, which is in agreement with literature Tg
value [41]. The first heating of pure DIC showed Tm at 288.2 ± 0.7
◦C, followed by an exothermic
event at 306.4 ± 0.8 ◦C and decomposed immediately at 320.92 ± 0.7 ◦C. Hence, no Tm and Tg were
detected for DIC during second heat. The highly crystalline IBU exhibited sharp Tm at 75.5 ± 0.1
◦C
when first heated, and then turned semi crystalline, with Tg and Tm detected during second heat, at
−42.7 ± 0.3 and 75.6 ± 0.2 ◦C respectively. The complete disappearance of characteristic pure drug
melting endotherms in all LID and IBU formulations loaded via both loading methods verified that
the different drug morphologies observed from SEM were amorphous. As for DIC formulations,
the presence of subtle endothermic peaks at approximately 165 and 255 ◦C (melting endotherms are
marked with asterisks in Figures 7 and 8) indicated two forms of diclofenac, respectively referring to
its acidic and salt form. Due to the irregularity in shape, the actual melting points of the polymorphs
could not be precisely determined. The conversion of drug to its acidic form was confirmed based on
the melting endotherm being close to the literature melting point diclofenac acid (156–158 ◦C) [42], and
presence of carboxylic acid functional groups identified from FT-IR. The rod-shaped crystals present
in the SEM micrograph of formulations post-loaded with 20.68% w/w DIC was also identified as
diclofenac acid by FT-IR. Comparing between loading methods, the amount of drug transformed into
its acidic and salt crystals was deemed higher for in situ loaded formulations, as the corresponding
melting endotherms were more obvious.
The typical thermograms obtained from first (cycle 1) and second (cycle 3) heating for formulations
containing the highest load for each model drug were respectively shown in Supplementary
Figures S1 and S2, with comparsion to those obtained from unmedicated ones and corresponding pure
drug. In order to rule out the possibility of ethanol (EtOH) instead of drug affecting the polymeric
network, blank hydrogel samples were subjected to the same process involved in the post loading of
IBU but without presence of drug, and the thermal profile of the resultant films was used as control for
IBU loaded formulations.
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Figure 7. DSC thermograms of post-loaded DIC formulations. (A) PEO-DIC 3.28% w/w (25%
saturation), (B) PEO-DIC 8.39% w/w (50% saturation), (C) PEO-DIC 13.62% w/w (75% saturation),
(D) PEO-DIC 20.68% w/w (100% saturation). Melting endotherms are marked with asterisks (*).
Figure 8. DSC thermograms of in situ loaded DIC formulations. (A) PEO-DIC 3.17% w/w, (B) PEO-DIC
8.37% w/w, (C) PEO-DIC 13.12% w/w, (D) PEO-DIC 20.26% w/w. Melting endotherms are marked
with asterisks (*).
The polymer’s melting endotherm obtained from first and second heat was very similar in all
formulations except for DIC formulations, where the melting endotherm from second heating was
sharper compared to the first heat. Hence, the crystallinity of the polymer network was accounted
based on second heat. The effect of loaded drugs on the crystallinity of polymeric network of xerogel
was assessed based on the percentage crystallinity (Xc) calculation, as shown in Equation (2) and
the findings are summarized in Table 4. The Tm and %XC of our unmedicated xerogel cross-linked
with pentaerythritol tetra-acrylate (PETRA) were found to be similar to PEO hydrogels synthesised
by Doytcheva et al. that were cross-linked with 5% w/w pentaerythritol triacrylate (PETA) [5].
EtOH treatment resulted in significant decrease in blank films %XC, but the change in crystallinity
portion was not prominent enough to cause significant depression on its corresponding Tm. Similar
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trend was also observed in all post-loaded LID formulations. The drug-polymer interaction was
more obvious in post-loaded DIC and IBU xerogel formulations, as significant decrease of %XC led to
significant depression of Tm, even at lower loads. All in situ loaded LID formulation possess similar
%XC and Tm as corresponding unmedicated ones, while the reductions in %XC and Tm were significant
in formulations in situ loaded with 13.12% w/w DIC and above. This concluded that the crystallinity
of PEO hydrogel network was more likely to be retained when drugs were loaded in situ, as was also
confirmed by FTIR (see Section 3.5).
Table 4. Effect of loading method and drug physicochemical properties on the melting temperatures
(Tm) and degree of crystallinity of hydrogel polymeric film. Tm and corresponding ∆H f values were
obtained from second heating (cycle 3). Values in brackets indicate the standard deviation from
reported mean (n = 3; * Significantly different from corresponding unmedicated hydrogels Significantly
different within groups; p < 0.05).
Sample Drug concentration (%w/w) Tm (Cycle 3) (
◦C) ∆Hf (J/g) XC (%)
Unmedicated - 63.1 (±0.9) 103.7 (±3.4) 52.7 (±1.7)
Unmedicated (350 ◦C) - 57.0 (±0.5) 145.5 (±1.9) 73.9 (±0.9)
Unmedicated (EtOH) - 61.9 (±1.3) 97.7 (±0.9) 49.6 (±0.5)
Post-loaded LID
1.18 62.3 (±0.5) 103.0 (±4.5) 52.3 (±2.3)
3.64 64.4 (±0.4) 95.2 (±3.3) * 48.4 (±1.7) *
6.31 63.9 (±0.5) 90.3 (±1.4) * 45.9 (±0.7) *
9.75 62.9 (±0.9) 87.3 (±2.1) * 44.4 (±1.1) *
Post-loaded DIC
3.28 58.5 (±0.2) 136.6 (±2.4) * 69.4 (±1.2) *
8.39 56.4 (±0.2) * 115.8 (±1.9) * 58.8 (±0.9) *
13.62 55.6 (±0.2) * 112.1 (±4.0) * 56.9 (±2.1) *
20.68 54.3 (±0.3) * 105.9 (±2.3) * 53.8 (±1.2) *
Post-loaded IBU
15.44 60.2 (±0.2) 75.6 (±2.7) * 38.4 (±1.4) *
31.01 55.3 (±0.1) * 61.3 (±3.0) * 31.1 (±1.5) *
45.48 51.3 (±2.1) * 49.8 (±5.0) * 25.3 (±2.5) *
59.09 51.0 (±5.1) * 46.7 (±5.9) * 23.8 (±3.0) *
In situ Loaded LID
1.12 64.6 (±0.8) 100.1 (±3.7) 50.9 (±1.9)
3.57 64.6 (±0.5) 102.3 (±3.8) 52.3 (±1.9)
6.3 64.5 (±0.2) 103.2 (±0.3) 52.4 (±0.1)
9.93 64.2 (±0.5) 98.9 (±1.1) 50.2 (±0.6)
In situ Loaded DIC
3.17 57.0 (±0.5) 139.0 (±7.8) 70.6(±3.9)
8.37 56.0 (±1.8) 133.7 (±5.4) * 68.0 (±2.7) *
13.12 55.4 (±0.5) * 119.0 (±0.2) * 60.5 (±1.0) *
20.26 52.6 (±0.4) * 99.8 (±2.6) * 50.7 (±1.3) *
3.5. FT-IR Analysis
3.5.1. Chemical Identification
The FT-IR of pure PEO, unmedicated PEO xerogel film, and EtOH treated unmedicated xerogel
films are illustrated in Figure 9. The characteristic peaks of PEO were assigned based on generally
accepted spectral interpretation [43,44]. Most of the characteristic peaks of pure PEO were attributed
to methylene (CH2) group, with related peaks occurring at 2877.79 cm
−1 (–CH2 symmetric stretching),
1467.83 cm−1 (–CH2 scissoring), 1359.82 and 1342.46 cm
−1 (–CH2 wagging), and 1276.88 cm
−1
(CH2 twisting). This confirmed that PEO possessed a certain extent of hydrophobic properties,
allowing the loading of IBU through hydrophobic interactions. Although PEO is typically considered
as hydrophilic, its hydrophobic properties have been documented [45,46]. The appearance of the two
previously mentioned –CH2 wagging peaks confirmed the high crystallinity of PEO [47]. Besides, the
spectra revealed presence of –C–O–C– absorption complex, as an apparent triplet peak occurring at
1143.78, 1095.57 (maximum intensity), and 1058.92 cm−1 was identified. This complex, resulting from
the combination of ether group andmethylene group, is very sensitive to polymer chain conformational
changes [48]. Hence, special attention was paid to its shape, intensity and shift for the detection of
possible interaction. It should be noted that the peak present at 2349.30 cm−1 was due to atmospheric
carbon dioxide [49]. The spectra of cross-linked unmedicated PEO xerogel film showed similar
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characteristic peaks as pure PEO with no additional peaks present. The intensity of –CH2 symmetric
stretching peak was slightly increased after cross-linking. Although the crosslinking of PEO via gamma
radiation was thought to widen and reduce the intensity of –C–O–C– complex [48], our results have
shown to be otherwise. This may be due to incorporation of PETRA in the UV cross-linking process.
In addition, two peaks of the triplet peak shifted from 1142 to 1144 cm−1, and 1094 to 1096 cm−1.
This suggested an increase in inter- and intra-molecular PEO interactions, most likely due to polymer
chains entanglement when PEO was premixed in distilled water during the synthesis of hydrogel
films [48]. For the case of EtOH-treated unmedicated film, the –CH2 symmetric stretching slightly
shifted to higher wavenumbers (2881.65 cm−1); this indicated weakening of hydrogen bond between
polymer chains, which may contribute to the small decrease in film crystallinity as observed in DSC.
Figure 9. FT-IR spectra of (a) pure PEO, (b) unmedicated PEO xerogel film, (c) EtOH treated
unmedicated PEO xerogel film.
Pure LID showed characteristic peaks at 3450.65 and 3383.14 cm−1 (amide N–H stretching),
1654.92 cm−1 (amide C=O stretching), and 1541.12 cm−1 (amide N–H bending) [50]. Besides, the
peaks located in the regions between 2300 and 2600 cm−1 were assigned to N–H vibrations of
hydrochloride salt [51]. Pure DIC exhibited distinctive peaks at 3388.93 cm−1 (secondary amine N–H
stretching), 1571.99 cm−1 (carboxylate COO− asymmetric stretching), 1556.55 cm−1 (dichlorophenyl
ring), 1498.69 cm−1 (phenyl acetate), and 1396.463 cm−1 (carboxylate COO− symmetric stretching) [52].
FT-IR absorption spectra of pure IBU revealed characteristic peaks at 2922.16 cm−1 (carboxylic acid
O–H stretching) and 1705.07 cm−1 (carboxylic acid C=O stretching) [53].
3.5.2. Effect of LoadingMethod and Drug Physicochemical Properties on the Drug-Polymer Compatibility
The FT-IR absorption spectra of all medicated xerogel films loaded via both drug-loading methods
in comparison to corresponding blank film andmodel drug are shown in Supplementary Figures S3–S7.
Presence of drug was confirmed in all formulations as their respective spectra revealed characteristic
peaks of loaded model drug. These peaks appeared either in separate form, or fused with the
characteristic peaks of unmedicated xerogel film. The spectra of post-loaded LID formulations
(Supplementary Figure S3) loaded in drug solution of 75% saturation and above, and all of post-loaded
IBU formulations (Supplementary Figure S5) were almost identical to the spectra of corresponding
model drug. This indicated presence of intact drug on film surface rather than being entrapped
into the polymeric network, as also observed using SEM. If the drug is completely entrapped
within the polymeric network, its characteristic peaks will not be detected [54]. The drug-polymer
interaction for post-loaded LID formulations is clearly detected in the spectra of those with a drug
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concentration of 3.64 % w/w (Supplementary Figure S3d). The polymer’s –CH2 symmetric stretching
merged with the drug’s hydrochloric salt N-H vibrations, resulting in a triplet peak complex with
maximum intensity at 2922.16 cm−1. In addition, the polymer –C–O–C– complex peak shifted to
lower wavenumbers (from 1095.57 to 972.12 cm−1 (maximum intensity) respectively) with decreased
intensity, indicating presence of inter-molecular hydrogen bonding. Furthermore, the reduced –CH2
wagging peak explained the decrease in polymer crystallinity of post-loaded LID formulations.
Although the spectra of all post-loaded DIC formulations (Supplementary Figure S4) appeared to
be a combination of pure drug and unmedicated xerogel film, the presence of additional peaks at
3645.47 and 3342.64 cm−1 (O–H stretching), and 1734.01 cm−1 (carboxylic acid C=O) confirms the
conversion of active drug from salt form to acid form. In addition, FT-IR study was specifically
performed on the rod-shaped crystals present in formulations post-loaded with 20.68% w/w DIC, as
observed from SEM. These crystals were identified as diclofenac acid, due to the appearance of O–H
and C=O stretching vibrations in their corresponding FT-IR spectra. The observation also verifies the
different diclofenac polymorphs observed from SEM. Due to the size of these peaks, it is concluded
that the amount of drug in acid form present in these formulations is fairly low. This correlates
well with the subtle thermal events corresponding to diclofenac acid as observed from DSC. As the
drug load increases, diclofenac acid’s characteristic carboxylic acid C=O gradually shifted to higher
wavenumber (corresponding peak shifted to 1737.86 cm−1) with decreasing intensity, which indicated
weakening of inter-molecular hydrogen bonding. In addition, the gradual reduction and shifting
towards lower wavelength from drug’s characteristic secondary amine N–H stretching peak and the
polymer –C–O–C– complex (from 3388.93 to 3383.14 cm−1 and from 1095.57 to 1093.64 cm−1 (maximum
intensity) respectively) with increasing drug load also suggested presence of inter-molecular hydrogen
bonding. Similar observation was found in IR spectra of post-loaded IBU formulations, as additional
peaks occurred at 3450.65 and 3385.07 cm−1. The increased intensity and shifting of drug characteristic
carboxylic acid C=O stretching towards higher wavenumbers (from 1705.07 to 1712.79 cm−1) and the
decreased intensity and shifting of polymer –C–O–C– complex peak towards lower wavenumbers
(peak with maximum intensity shifted from 1095.57 to 1072.42 cm−1) for formulations with lower
loading provide strong evidence of hydrogen bonded IBU with PEO film. Comparison between
post-loaded and in situ loaded formulations, showed that the in situ loading method provides better
drug entrapment within the hydrogel network due to absence of spectra same or near identical to pure
drug. The lack of intact drug on film surface of post-loaded formulations is supported by SEM findings.
Moreover, the drug-polymer interaction is influenced by the loading method, as different spectral
changes were observed between formulations containing the same drug but loaded differently, thus
explaining the different polymer crystallinity as observed in DSC. The better resemblance of in situ
loaded formulations spectra to the polymer PEO spectrum also implied less drug-polymer interaction,
hence verifies the conclusion from DSC analysis regarding the likelihood of polymer crystallinity being
maintained when drugs were loaded via in situ loading method. For in situ loaded LID formulations
(Supplementary Figure S6), the triplet peak complex with maximum intensity at 2922.16 cm−1,
observed in the spectra of post-loaded ones, was not present. Instead, the presence of hydrogen
bonding was indicated, as the polymer’s –C–O–C– complex shifted to lower wavenumber (peak with
maximum intensity shifted from 1095.67 to 1035.74 cm−1) with decreasing intensity as the drug load
increases. The presence of diclofenac acid was also confirmed in in situ loaded DIC formulations
(Supplementary Figure S7), as additional peaks were observed at 3450.62 (O–H stretching) and
1718.58 cm−1 (carboxylic acid C=O). These characteristic peaks appeared differently when compared
to post-loaded DIC formulations, thus supported the observation of drug morphology being affected
by loading method. In addition, the characteristic peaks were also more prominent compared to the
ones observed from post-loaded formulations, hence implying the amount of drug converted from
salt form to acid form was higher. This is in agreement with the more obvious diclofenac acid melting
endotherm observed from DSC. As the loading concentration increases, the peak corresponding to
diclofenac acid’s carboxylic acid C=O shifted to higher wavenumbers (from 1718.58 to 1737.86 cm−1)
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with reduced intensity, indicating weakening of inter-molecular hydrogen bonding. Furthermore,
the polymer’s –CH2 symmetric stretching gradually shifted to lower wavenumber (from 2877.79 to
2875.87 cm−1) with increasing intensity, which suggested increase in intermolecular stabilization due
to longer chains [55]. This observation verifies the formulations’ higher average molecular weight
between crosslink calculated from swelling studies. Overall, the reduction in the formulations’ drug
characteristic peaks relative to pure drug implied decrease in drug crystallinity and change into
amorphous form [56].
3.6. Effect of Loading Method and Drug Physicochemical Properties on the Mechanical Properties
The effect of loaded drugs on the mechanical properties is presented in Table 5. It can be
seen that ethanol treatment did not cause significant changes to the mechanical properties of
hydrogels. As expected, the tensile strength and percentage elongation of all post-loaded formulations
were comparable to the corresponding unmedicated hydrogels, due to morphological similarities.
The post-loading of LID did not have an effect on film’s tensile strength but gave a slight increase
on their percentage elongation. Therefore, the decrease in corresponding Young’s moduli were
insignificant (p > 0.05). The effect of post-loaded drugs in reducing the mechanical properties of
hydrogel films was more obvious for the case of DIC and IBU formulations. This can be attributed
to drug causing significant decrease in the polymer crystallinity. On the other hand, the mechanical
properties of in situ loaded formulations were significantly different from unmedicated hydrogels.
In situ loaded LID seem to have a plasticizing effect, causing a moderate decrease in formulations’
tensile strength and Young’s modulus, while dramatically improved the percentage elongation
(up to 50% improvement). The marked decrease in the mechanical properties of in situ loaded
DIC formulations was due to the low cross-linking density resulting in significantly weaker films.
Nonetheless, these observations agree with findings from SEM, swelling studies, DSC and FT-IR.
Table 5. Effect of loading method and drug physicochemical properties on the mechanical properties.
Values in brackets indicate the standard deviation from reported mean (n = 3; * Significantly different
from corresponding unmedicated hydrogels; p < 0.05).
Sample
Drug concentration
(% w/w)
Tensile strength
(MPa)
Percentage elongation
(%)
Young’s modulus
(MPa)
Unmedicated - 1.25 (±0.05) 19.84 (±2.75) 7.87 (±0.30)
Unmedicated (EtOH) - 1.21 (±0.13) 19.86 (±2.94) 7.61 (±0.11)
Post-loaded LID
1.18 1.20 (±0.09) 20.23 (±2.03) 7.41 (±0.53)
3.64 1.25 (±0.08) 20.05 (±2.42) 7.79 (±0.58)
6.31 1.31 (±0.11) 21.75 (±1.79) 7.52 (±0.46)
9.75 1.32 (±0.07) 22.64 (±1.44) 7.28 (±0.47)
Post-loaded DIC
3.28 1.20 (±0.07) 20.49 (±1.09) 7.31 (±0.51)
8.39 1.15 (±0.11) 21.27 (±1.89) 6.75 (±0.59) *
13.62 1.12 (±0.10) 22.39 (±2.36) 6.24 (±0.42) *
20.68 1.08 (±0.11) * 22.74 (±1.96) 5.93 (±0.21) *
Post-loaded IBU
15.44 1.20 (±0.08) 20.12 (±1.01) 7.45 (±0.48)
31.01 1.19 (±0.05) 21.87 (±2.10) 6.80 (±0.55) *
45.48 1.17 (±0.05) 22.36 (±2.42) 6.54 (±0.57) *
59.09 1.15 (±0.03) 23.95 (±2.97) 6.00 (±0.71) *
In situ Loaded LID
1.12 1.14 (± 0.14) 22.18 (±2.61) 6.42 (±0.24) *
3.57 0.82 (±0.02) * 26.37 (±2.70) * 3.88 (±0.16) *
6.3 0.56 (±0.03) * 32.53 (±3.28) * 2.15 (±0.25) *
9.93 0.50 (±0.04) * 40.01 (±3.05) * 1.56 (±0.18) *
In situ Loaded DIC
3.17 0.19 (±0.03) * 24.13 (±3.49) * 0.98 (±0.04) *
8.37 0.14 (±0.02) * 35.30 (±5.60) * 0.50 (±0.03) *
13.12 0.10 (±0.02) * 43.39 (±8.39) * 0.29 (±0.04) *
20.26 0.05 (±0.02) * 54.68 (±7.80) * 0.11 (±0.04) *
3.7. Effect of Loading Method and Drug Physicochemical Properties on the Rheological Properties
The effect of loaded drugs on the rheological properties is summarized in Table 6. No values
were presented for 8.3% w/w and above in- situ loaded DIC formulations, as no linear viscoelastic
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regions (LVR) were obtained during the study, indicating insufficient cross-linking to form a stable
microstructure. This observation agreed with their irregular and scarce gel network observed from
SEM and their largely deviated swelling parameters. The lack of cross-link formation in these
formulations may be due to chlorine atoms of DIC moiety forming free radicals under UV radiation.
This is thought to deactivate the PETRA radicals. As a result, less PEO radicals were generated
for cross-linking. From Table 6, it can be seen that all loaded formulations, except those containing
1.18% w/w post-loaded LID showed significant increase in elastic modulus (G’). In addition, the G’
increases with increasing drug load, indicating the increase of undissolved drug present in film [57].
All G’ values were obviously higher than viscous modulus (G”) indicated all tested films behaved
more solid-like. The high G’ values in comparison to corresponding G” observed in situ loaded LID
formulations indicated pronounced elastic deformation under shear stress, which agrees with the films’
high toughness observed from tensile testing. The increase of viscous modulus (G”) is thought to be
related to the significant decrease in polymer crystallinity, as the increase in polymer chain movement
resulted in an increase in flow properties. For both loading methods, the increase of drug concentration
generally decreased the microstructure stability. This is reflected through the decrease in critical strain
(γ0) values. γ0 is known as the critical oscillatory strain a hydrogel film can withstand before bond
breakage occurs [58]. The moduli of all tested films were independent of frequency, showing no
change in degree of viscoelasticity. This is typical of gel behaviour and indicative of a homogeneous
cross-linked network. The complex viscosity (η∗) is a frequency-dependent modulus accounting for
both the elastic and viscous properties of a material. The higher the η∗ value, the more solid-like the
material is and/or the greater is the resistance to flow [59]. Hence, the relationship between η∗ and
drug release rate is expected to be inversely proportional. Increase of drug concentration generally
increased the formulations’ η∗ values (Table 6). The in situ loaded LID formulations possessed the
highest η∗ values among all, which correlated well with their improved tensile strength and percentage
elongation. Overall, all formulations’ η∗ values were found to decrease with increasing oscillatory
frequency, thus confirming the shear-thinning behaviour of the tested films [60].
Table 6. Effect of loading method and drug physicochemical properties on the mechanical properties.
Values in brackets indicate the standard deviation from reported mean (n = 3; * Significantly different
from corresponding unmedicated hydrogels; p < 0.05).
Sample
Drug concentration
(% w/w)
Elastic modulus,
G’ 104 (Pa)
Viscous modulus,
G” 104 (Pa)
Critical strain
(γ0)
Complex viscosity at
frequency = 10 Hz,
η* 103 (Pa·s)
Unmedicated - 9.27 (±0.12) 1.04 (±0.33) 1.68 1.57 (±0.21)
Unmedicated (EtOH) - 9.03 (±0.10) 1.14 (±0.29) 1.58 1.65 (±0.18)
Post-loaded LID
1.18 9.40 (±0.14) 1.05 (±0.08) 1.59 1.57 (±0.05)
3.64 10.52 (±0.19) * 1.15 (±0.15) 0.99 1.67 (±0.17)
6.31 10.71 (±0.16) * 1.18 (±0.07) 0.67 1.69 (±0.08)
9.75 11.54 (±0.22) * 1.26 (±0.07) 0.4 1.78 (±0.12)
Post-loaded DIC
3.28 9.89 (±0.22) * 1.11 (±0.29) 1.58 1.63 (±0.12)
8.39 11.79 (±0.03) * 1.33 (±0.33) 1.25 1.83 (±0.06)
13.62 14.44 (±0.23) * 1.41 (±0.30) 0.84 1.97 (±0.25)
20.68 17.16 (±0.21) * 1.64 (±0.27) * 0.53 2.06 (±0.29)
Post-loaded IBU
15.44 10.97 (±0.38) * 1.16 (±0.41) 1.26 1.69 (±0.16)
31.01 12.18 (±0.45) * 1.87 (±0.17) * 1 2.25 (±0.33) *
45.48 17.65 (±0.71) * 3.12 (±0.42) * 0.62 3.02 (±0.45) *
59.09 20.54 (±0.48) * 4.32 (±0.19) * 0.31 3.69 (±0.31) *
In situ Loaded LID
1.12 10.20 (± 0.13) * 1.13 (±0.33) 0.79 1.64 (±0.04)
3.57 24.35 (±0.23) * 1.54 (±0.20) 0.63 3.58 (±0.09) *
6.3 28.62 (±0.30) * 1.59 (±0.27) 0.63 4.87 (±0.15) *
9.93 39.22 (±0.14) * 1.75 (±0.19) * 0.5 6.34 (±0.34) *
In situ Loaded DIC
3.17 0.42 (±0.13) * 0.03 (±0.01) * 0.63 0.04 (±0.01) *
8.37 - - - -
13.12 - - - -
20.26 - - - -
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3.8. Effect of Loading Method and Drug Physicochemical Properties on the Drug Release Behaviour via
a Synthetic Membrane
3.8.1. pH and Drug Ionization
The ionization of drugs was evaluated, as it is expected to significantly impact the transdermal
delivery of drugs, in terms of release kinetics, permeability, and absorption via passive diffusion.
In most cases, the outermost of skin (stratum corneum) permeability coefficient for non-ionized
species of a drug is 1–2 orders of magnitude larger than the permeability coefficient of its ionized
counterpart [61]. Table 7 summarized the calculated percentage drug ionization expected in
formulations containing drug in salt forms, and in release medium (phosphate buffer pH 7.2), based
on formulation experimental pH measurements and literature drug pKa values. The applicability
of all studied formulations for dermatological use is confirmed, as their apparent pH values were
nearly similar to the pH of skin (pH 4.5–6.5) [62]. LID loaded from both loading methods was almost
completely ionized, with some of its non-ionized counterpart expected to be present in the release
medium. The high ionization of the drug may contribute to the lower hydrogel post-loading capacity,
as PEO itself is a non-ionic polymer [63]. In the case of anionic polymer gels, the loading of LID
should be higher due to the presence of opposite charges. Contrastingly, almost all loaded DIC was
non-ionized when present in both the film and release medium. Hence, the loading of DIC was higher.
Table 7. Effect of loading method and drug physicochemical properties on the drug ionization. Values
in brackets indicate the standard deviation from reported mean (n = 3; * Significantly different from
corresponding unmedicated hydrogels; p < 0.05).
Sample
Drug concentration
(% w/w)
Apparent pH
Drug ionization
in film (%)
Drug ionization in
phosphate buffer pH 7.2 (%)
Unmedicated - 5.61 (±0.01) - -
Unmedicated (EtOH) - 5.61 (±0.00) - -
Post-loaded LID 9.75 5.80 (±0.00) * 99.14 82.05
Post-loaded DIC 20.68 6.71 (±0.00) * 0.27 0.09
Post-loaded IBU 59.09 4.66 (±0.01) * - -
In situ Loaded LID 9.93 6.34 (±0.01) * 97.07 82.05
In situ Loaded DIC 20.26 6.75 (±0.01) * 0.25 0.09
3.8.2. Effect of Loading Method and Drug Physicochemical Properties on the Permeation Studies
The cumulative percentage of drug permeated from all studied post-loaded and in-situ loaded
formulations are presented in Supplementary Figures S8 and S9, respectively. Based on the figures,
the in vitro permeation profiles of PEO hydrogels were significantly affected by the loading method
and physicochemical properties of drug. The permeation rates from post-loaded formulations are
generally more rapid compared to the in situ loaded ones. This may be due to drug being deposited in
microporous spaces of gel when post-loaded (as observed in SEM), instead of being embedded within
polymeric network when loaded in situ. As a result, the post-loaded drugs were instantaneously
released when hydrated. It is note-worthy that the EVA membrane was presoaked in phosphate
buffer pH 7.2 before usage, to ensure all of its pores were hydrated. This may contribute to the
near complete release of LID despite the high ionization, as the drug became solubilized when came
into contact with buffer. The Co Tran 9702 EVA membrane was used to mimic skin permeability,
as its pore size (50.8 µm) [64] is comparable to the pore size of normal abdominal skin (50 µm) [65].
In fact, the transdermal delivery of hydrophilic/ionized drugs is thought to be improved by hydrogels.
The high water content of synthesized hydrogel films can act as natural penetration enhancer, as
constant hydration of the stratum corneum through prolonged occlusion (24–48 h) achievable by
using impermeable foil as backing layer of hydrogel films can lead to the swelling of corneocytes [66].
Besides, the polar water molecules may interact with the hydrophilic lipid heads, causing modification
in the packing and orientation of lipid bilayer [67]. All of these are thought to create extra “pores”
in the stratum corneum, allowing hydrophilic/ionized drug molecules to penetrate or permeate
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readily into the skin. Although the rod-shaped diclofenac acid crystals present in post-loaded DIC
formulations were known to exhibit lower solubility compared to its sodium salt [68], the release of
these crystal from the hydrogel formulation may be attributed to the ionization of the compound in
phosphate buffer pH 7.2 (diclofenac acid pKa = 4.5) [69]. Hence, post-loaded DIC formulations at
saturated concentration were capable of near complete drug release. Comparing between post-loaded
formulations, drug flux (µg/cm2/h) of hydrophobic IBU is obviously different from those loaded with
hydrophilic LID and DIC, as the drug took longer time (approximately 24 h) to reach near complete
permeation. This suggested a different release mechanism for IBU from the hydrogel. It is thought that
the release of hydrophilic/ionic compounds from hydrogels was governed by diffusion mechanism,
whereas hydrophobic compounds were initially released by diffusion [70] and then through polymer
degradation [71]. In addition, the formulation’s higher complex viscosity may contribute to the release
retardation, as this indicated a more viscous gel layer, which can decrease the diffusion co-efficient
of drug release in the hydrogels [72]. The mean total drug permeation from in situ loaded DIC
formulations was only 63.04 (±2.18) % even after being left for longer than 72 h. This observation
agreed with the suggestion of DIC interacting with PETRA under presence of UV radiation, as some
DIC molecules were covalently bound to the polymer matrix.
For confirmation purposes, the total percentages of drug release obtained from the UV
measurements were compared with the percentage release values calculated by weight method, using
Equation (11). The results are tabulated in Table 8. From the table, it can be seen that percentage release
value of post-loaded DIC hydrogel sample obtained from weight loss calculation were significantly
higher than the ones measured by UV. This is due to the low crosslink density of formulations resulting
significant loss of sample weight during the release study. For this reason, the percentage drug release
for this studied formulation is more accurate when measured by UV. Apart from that, the total release
percentages for all other formulations obtained from both methods agreed with one another.
Table 8. Comparison of total percentage drug release obtained from release studies to percentage
release values calculated by weight measurements. Values in brackets indicate the standard deviation
from reported mean (n = 4; * Significantly different between compared values).
Formulation
Drug concentration
(% w/w)
Mean total percentage drug release
from UV measurements (%)
Mean total percentage drug release
based on weight measurements (%)
Post-loaded LID 9.75 92.60 (±2.26) 93.77 (±0.24)
Post-loaded DIC 20.68 93.90 (±2.27) 94.52 (±0.59)
Post-loaded IBU 59.09 96.82 (±2.95) 99.60 (±0.62)
In situ Loaded LID 9.93 97.53 (±1.08) 98.45 (±0.12)
In situ Loaded DIC 20.26 63.04 (±2.18) * 120.75 (±2.32) *
3.8.3. Effect of Loading Method and Drug Physicochemical Properties on the Release Kinetics
The in vitro permeation profiles of studied formulations were fit to different kinetic models
and the results were tabulated in Table 9. The kinetic model best fitted to the permeation data
was determined based on the regression coefficient (R2). It was found that post-loaded LID, DIC,
and in situ loaded LID formulations followed both the zero order and Higuchi models. This dual
release mechanism is verified by the Korsmeyer-Peppas model, as the obtained ‘n’ values indicated
non-Fickian diffusion (0.5 < n < 1), which means that the overall release rate is contributed by both
drug diffusion and polymer chain relaxation [3]. Although the permeation data from post-loaded IBU
formulations were best fitted under zero order release model (constant drug release over time), their
Korsmeyer-Peppas model ‘n’ value showed quasi-Fickian diffusion (n < 0.5), indicating a coupling of
diffusion and erosion mechanism [73]. As for in situ loaded DIC formulations, the release rate followed
first order kinetics, indicating the drug release rate is dependent on its concentration. Based on their
corresponding Korsmeyer-Peppas ‘n’ value, the diffusion mechanism followed super case II transport
mechanism (n > 1), indicated their release is most likely driven by macromolecular chain relaxation
and swelling of hydrophilic polymer chain [74]. All these observations concluded that the release of
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drug from hydrogel films is heavily dependent on both drug physicochemical properties and material
properties of hydrogel films.
Table 9. Effect of loading method and drug physicochemical properties on the release kinetics.
Formulation
Drug concentration
(% w/w)
Zero order First order Higuchi model Korsmeyer-peppas model
R2 K0 R
2 K1 R
2 K2 R
2 K3 n
Post-loaded LID 9.75 0.961 13.016 0.962 1.511 0.961 13.016 0.999 1.536 0.788
Post-loaded DIC 20.68 0.958 15.349 0.966 1.595 0.958 15.349 0.995 1.621 0.733
Post-loaded IBU 59.09 0.993 3.343 0.986 0.575 0.995 4.571 0.989 0.006 0.015
In situ Loaded LID 9.93 0.994 8.099 0.987 0.744 0.994 8.099 0.970 0.908 0.786
In situ Loaded DIC 20.26 0.956 6.3498 0.982 1.398 0.962 6.774 0.981 1.403 1.811
4. Conclusions
The effects of loading methods and drug physicochemical properties on both the material and
release properties of PEO hydrogel films were extensively studied. It was concluded that PEO hydrogel
film patches synthesized via UV cross-linking can be formulated as transdermal patches with high
drug loading, robust mechanical properties, and optimum drug release. The different loading methods
resulted in significantly different gel profiles, and the suitability of each method is dependent on
individual drug pharmaceutical properties and desired use; post-loaded films showed immediate
drug release whereas in situ loaded films showed prolonged drug release. The majority of medicated
PEO hydrogel formulations followed both zero order and Higuchi release pattern, which is highly
desirable for controlled release formulations.
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to pure IBU and unmedicated PEO xerogel film, Figure S6: FT-IR spectra of in-situ loaded LID formulations
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